Last reviewed · How we verify
NCT07268235
Timing of Oocyte Retrieval and Micro Testicular Sperm Extraction
trial in Microdissection Testicular Sperm Extraction in 129 participants. Completed in 30 November 2025.
30 November 2025
Quick facts
| Lead sponsor | Clinique Ovo |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 129 |
| Start date | 15 November 2025 |
| Primary completion | 30 November 2025 |
| Estimated completion | 30 November 2025 |
| Sites | 1 location across Canada |
Conditions studied
- Microdissection Testicular Sperm Extraction — all drugs for Microdissection Testicular Sperm Extraction →
Sponsor
Clinique Ovo — full company profile →
Who can join
18 and older, male only, with Microdissection Testicular Sperm Extraction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a retrospective study to assess outcomes of micro-TESE performed 24 or 48 hours before oocyte retrieval and ICSI.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07268235
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Clinique Ovo trials
Trials by the same sponsor.
- NCT07286279 — Identifying Candidates for Limited Dissection at Microdissection TESE. · completed
- NCT07457684 — Comparison of Follitropin Delta and Follitropin Alfa in Combination With Menotropin · completed
- NCT06502665 — Second Ovulation Induction · completed
- NCT06290921 — Ovulation Triggering 2 vs 3 Follicles · completed
- NCT06290895 — Artificial Oocyte Activation · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07268235 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Clinique Ovo
- Last refreshed: 5 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07268235.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing